Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 56 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Polyzos, S A [Clear All Filters]
Acromegaly: presentation, morbidity and treatment outcomes at a single centre..
Int J Clin Pract. 65(8), 896-902.
(2011). Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas..
Int J Clin Pract. 65(3), 373-4.
(2011). Association between Helicobacter pylori burden and Alzheimer's disease..
Eur J Neurol. 21(12), e100.
(2014). Associations of estrogen receptor alpha and beta gene polymorphisms with sex steroid levels and body fat content in men..
Exp Clin Endocrinol Diabetes. 120(3), 154-9.
(2012). Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment..
Osteoporos Int. 24(7), 2127-32.
(2013). Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months..
Osteoporos Int. 25(5), 1633-42.
(2014). Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events..
Int J Obes (Lond). 39(1), 156-61.
(2015). Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment..
Horm Metab Res. 46(2), 145-9.
(2014). Coincidence of severe primary hyperparathyroidism and primary hypothyroidism in a postmenopausal woman with low bone mass--initial conservative management..
J Musculoskelet Neuronal Interact. 11(1), 77-80.
(2011). Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia"..
Eur Rev Med Pharmacol Sci. 20(1), 3-4.
(2016). Commentary: are blood and saliva sources of COVID-19 spread?.
Eur Rev Med Pharmacol Sci. 25(15), 4872-4874.
(2021).
(2011).
(2013). Denosumab for the treatment of primary pediatric osteoporosis..
Osteoporos Int.
(2021). Denosumab versus zoledronic acid in patients previously treated with zoledronic acid..
Osteoporos Int. 26(10), 2521-7.
(2015). Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide..
Horm Metab Res. 41(7), 559-62.
(2009). The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone..
Horm Metab Res. 41(11), 846-50.
(2009). Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis..
Horm Metab Res. 41(10), 721-9.
(2009). The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease..
Curr Mol Med. 12(1), 68-82.
(2012). The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration..
Curr Mol Med. 17(6), 389-404.
(2017). Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004)..
Exp Clin Endocrinol Diabetes. 116(8), 496-500.
(2008). Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases..
Curr Mol Med. 11(8), 696-707.
(2011). Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial..
Int J Clin Pract. 62(6), 919-24.
(2008). Helicobacter pylori infection and Parkinson's disease: apoptosis as an underlying common contributor..
Eur J Neurol. 19(6), e56.
(2012). Helicobacter pylori may be involved in stroke pathophysiology by altering tumor necrosis factor-α and matrix metalloproteinases..
Eur J Neurol. 18(7), e76; author reply e77.
(2011).